➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
AstraZeneca
Express Scripts
McKinsey

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Cytisine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Cytisine?

Cytisine is an investigational drug.

There have been 13 clinical trials for Cytisine. The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2019.

The most common disease conditions in clinical trials are Coronary Artery Disease, Behavior, Addictive, and Inflammation. The leading clinical trial sponsors are Achieve Life Sciences, University of Auckland, New Zealand, and Mongolian National University of Medical Sciences.

There are two hundred and forty-six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Cytisine
TitleSponsorPhase
A Study of Cytisinicline for Smoking Cessation in Adult SmokersAchieve Life SciencesPhase 3
Pilot RCT of Cytisine vs Combination NRT in Relapsed SmokersOttawa Heart Institute Research CorporationN/A
Comparative Effectiveness of Cystine Versus Nicotine Replacement TherapyMongolian National University of Medical SciencesPhase 3

See all Cytisine clinical trials

Clinical Trial Summary for Cytisine

Top disease conditions for Cytisine
Top clinical trial sponsors for Cytisine

See all Cytisine clinical trials

US Patents for Cytisine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cytisine   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Cytisine   Start Trial Nicotinic attenuation of CNS inflammation and autoimmunity Dignity Health (San Francisco, CA)   Start Trial
Cytisine   Start Trial Dietary supplements and formulations Eastern Vision Limited (Wanchai, HK)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cytisine

Drugname Country Document Number Estimated Expiration Related US Patent
Cytisine World Intellectual Property Organization (WIPO) WO2014052836 2032-09-27   Start Trial
Cytisine Canada CA2736871 2028-09-11   Start Trial
Cytisine World Intellectual Property Organization (WIPO) WO2010030887 2028-09-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
AstraZeneca
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.